Sapporo, Japan

Jun Shao

This inventor holds 1 USPTO granted patent. Top assignee: Theravalues Corporation. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Shao. Retrieved from https://idiyas.com/inventor/jun-shao-tuxd542j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jun Shao - Innovator in Pharmaceutical Chemistry

Introduction

Jun Shao is a notable inventor based in Sapporo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on oxindole derivatives. His research has the potential to impact various therapeutic applications.

Latest Patents

Jun Shao holds a patent for an oxindole derivative. This compound or a pharmaceutically acceptable salt thereof is represented by a specific general formula. The formula includes various substituents such as hydrogen atoms, halogen atoms, hydroxy groups, and alkyl groups, among others. This innovation showcases his expertise in developing new chemical entities for medicinal use.

Career Highlights

Throughout his career, Jun Shao has been associated with Theravalues Corporation, where he has been able to apply his knowledge and skills in a collaborative environment. His work has led to advancements in pharmaceutical formulations and has contributed to the company's research initiatives.

Collaborations

Jun Shao has worked alongside esteemed colleagues such as Noriaki Shinobu and Masataka Kobayashi. Their combined efforts have fostered a productive research atmosphere, leading to innovative solutions in the pharmaceutical sector.

Conclusion

Jun Shao's contributions to the field of pharmaceutical chemistry, particularly through his patent on oxindole derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…